MEI Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	Current	2023	2022	2021	2020	2019	2018 - 2004
Market Capitalization	19	44	81	321	438	178	Upgrade
Market Cap Growth	-12.63%	-45.58%	-74.90%	-26.70%	145.63%	21.20%	Upgrade
Enterprise Value	-26	-44	-63	176	255	104	Upgrade
PE Ratio	0.71	-1.38	-1.48	-7.77	-9.28	-10.60	Upgrade
PS Ratio	0.28	0.90	1.98	9.22	15.77	36.26	Upgrade
PB Ratio	0.37	1.78	1.54	6.49	5.68	3.72	Upgrade
P/FCF Ratio	-0.61	-0.83	-1.64	-9.82	13.12	-6.01	Upgrade
P/OCF Ratio	-0.61	-0.84	-1.65	-10.04	12.78	-6.06	Upgrade
EV/Sales Ratio	-0.27	-0.90	-1.55	5.05	9.19	21.11	Upgrade
EV/EBITDA Ratio	-0.65	1.47	1.18	-4.28	-5.42	-6.20	Upgrade
EV/EBIT Ratio	-0.70	1.39	1.16	-4.26	-5.41	-6.17	Upgrade
EV/FCF Ratio	0.42	0.84	1.28	-5.38	7.65	-3.50	Upgrade
Debt / Equity Ratio	0.23	0.52	0.18	0.17	-	-	Upgrade
Debt / EBITDA Ratio	0.42	-0.42	-0.18	-0.20	-	-	Upgrade
Debt / FCF Ratio	-0.27	-0.24	-0.20	-0.25	-	-	Upgrade
Quick Ratio	5.88	4.95	6.68	7.97	13.48	5.21	Upgrade
Current Ratio	6.17	5.29	6.84	8.15	15.17	5.75	Upgrade
Asset Turnover	0.72	0.35	0.22	0.18	0.23	0.06	Upgrade
Return on Equity (ROE)	48.30%	-88.00%	-95.60%	-66.00%	-68.30%	-37.60%	Upgrade
Return on Assets (ROA)	28.10%	-22.50%	-28.70%	-21.20%	-39.10%	-18.70%	Upgrade
Return on Capital (ROIC)	35.79%	-98.43%	-121.64%	-104.60%	-33.35%	-96.48%	Upgrade
Earnings Yield	140.20%	-72.62%	-67.60%	-12.87%	-10.78%	-9.44%	Upgrade
FCF Yield	-234.91%	-119.79%	-61.11%	-10.18%	7.62%	-16.63%	Upgrade
Dividend Yield	43.80%	0.00%	0.00%	0.00%	0.00%	0.00%	Upgrade
Payout Ratio	44.60%	0.00%	0.00%	0.00%	0.00%	0.00%	Upgrade
Buyback Yield / Dilution	-6.49%	-9.31%	-25.69%	-25.83%	-74.71%	Upgrade
Total Shareholder Return	43.80%	-6.49%	-9.31%	-25.69%	-25.83%	-74.71%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).